Canopy Growth (CGC) Net Margin (2019 - 2025)

Canopy Growth (CGC) reported Net Margin of 7.47% for Q3 2025, down 1264.0% on a YoY basis from 0.64% in Q3 2024, and down 244.38% sequentially from 5.17% in Q3 2024.

Canopy Growth (CGC) Net Margin (2019 - 2025) Analysis & Trends

Canopy Growth (CGC) has 7 years of Net Margin data on file, last reported at 7.47% in Q3 2025.

  • For the quarter ending Q3 2025, Net Margin fell 1264.0% year-over-year to 7.47%; the trailing twelve-month figure through Dec 2025 stood at 1.18% (down 396.0% YoY), and the FY2026 full-year result was 8.08%, down 12017.0% from the prior year.
  • Net Margin declined to 7.47% in Q3 2025, from 5.17% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 286.29% in Q2 2021 to a low of 1762.71% in Q2 2022.
  • A 5-year average of 123.9% and a median of 26.73% in 2021 frame the typical range for Net Margin.
  • Across the five-year window, Net Margin jumped 469707 bps in 2021 and slumped 204900 bps in 2022, its largest moves.
  • Tracing CGC's Net Margin over 5 years: stood at 74.5% in 2021, then soared by 41 bps to 44.23% in 2022, then surged by 139 bps to 17.17% in 2023, then sank by 70 bps to 5.17% in 2024, then sank by 244 bps to 7.47% in 2025.
  • Business Quant data shows CGC's Net Margin at 7.47% in Q3 2025, 5.17% in Q3 2024, and 3.1% in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 Canopy Growth 197.77 Mn -68.15 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -7.47%
Sep 30, 2024 5.17%
Jun 30, 2024 3.10%
Mar 31, 2024 3.21%
Dec 31, 2023 17.17%
Sep 30, 2023 -253.81%
Jun 30, 2023 -41.03%
Mar 31, 2023 -51.30%
Dec 31, 2022 -44.23%
Sep 30, 2022 -124.34%
Jun 30, 2022 -1,762.71%
Mar 31, 2022 149.15%
Dec 31, 2021 -74.50%
Sep 30, 2021 -12.43%
Jun 30, 2021 286.29%
Mar 31, 2021 -74.67%
Dec 31, 2020 -4,771.57%
Sep 30, 2020 -71.38%
Jun 30, 2020 -107.75%
Mar 31, 2020 -1,357.31%